All Stories

  1. Sulfated Alginate for Biomedical Applications

    Article • Macromolecular Bioscience, July 2024, Wiley

    Dr Vito Ferro

  2. Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2

    Article • Journal of Medicinal Chemistry, July 2024, American Chemical Society (ACS)

    Dr Vito Ferro

  3. Site-Selective Photobromination of O-Acetylated Carbohydrates in Benzotrifluoride

    Article • Organic Letters, July 2024, American Chemical Society (ACS)

    Dr Vito Ferro

  4. Origins of Temperature‐Dependent Anomeric Selectivity in Glycosylations with an L‐Idose Thioglycoside

    Article • Chemistry - A European Journal, July 2024, Wiley

    Dr Vito Ferro

  5. Antiviral Activities of Heparan Sulfate Mimetic RAFT Polymers Against Mosquito-borne Viruses

    Article • ACS Applied Bio Materials, May 2024, American Chemical Society (ACS)

    Dr Vito Ferro

  6. Synthesis of sulfated alginate from its tributylammonium salt: Comparing the sulfating agents H2SO4-DCC and SO3·py

    Article • Carbohydrate Polymers, January 2024, Elsevier

    Dr Vito Ferro

  7. Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    Dr Vito Ferro

  8. C-5 Epimerisation of D-Mannopyranosyl Fluorides: The Influence of Anomeric Configuration on Radical Reactivity

    Article • Synthesis, August 2023, Thieme Publishing Group

    Dr Vito Ferro

  9. Substrate reduction therapy in aDrosophila melanogastermodel of Sanfilippo syndrome

    Article • March 2023, Cold Spring Harbor Laboratory Press

    Dr Vito Ferro

  10. A prohibitin-targeting drug modifies aspects of disease in a mouse model of Sanfilippo syndrome

    Article • Molecular Genetics and Metabolism, February 2023, Elsevier

    Dr Vito Ferro

  11. Synthesis of Uronic Acid 1‐Azasugars as Putative Inhibitors of α‐Iduronidase, β‐Glucuronidase and Heparanase**

    Article • ChemBioChem, January 2023, Wiley

    Dr Vito Ferro

  12. Siderophore conjugates to combat antibiotic-resistant bacteria

    Article • RSC Medicinal Chemistry, January 2023, Royal Society of Chemistry

    Dr Vito Ferro

  13. An Enzymatic Activity Assay for Heparanase That Is Useful for Evaluating Clinically Relevant Inhibitors and Studying Kinetics

    Article • January 2023, Springer Science + Business Media

    Dr Vito Ferro

  14. Synthesis of a Gal-β-(1→4)-Gal disaccharide as a ligand for the fimbrial adhesin UcaD

    Article • Australian Journal of Chemistry, December 2022, CSIRO Publishing

    Dr Vito Ferro

  15. Evidence for Multiple Binding Modes in the Initial Contact Between SARS‐CoV‐2 Spike S1 Protein and Cell Surface Glycans**

    Article • Chemistry - A European Journal, November 2022, Wiley

    Dr Vito Ferro

  16. An Improved Protocol for the Stereoselective Synthesis of β-d-Glycosyl Fluorides from 2-O-Acyl Thioglycosides

    Article • The Journal of Organic Chemistry, October 2022, American Chemical Society (ACS)

    Dr Vito Ferro

  17. Initial contact between SARS-CoV-2 spike S1 protein and cell surface glycans involves multiple binding modes

    Article • April 2022, American Chemical Society (ACS)

    Dr Vito Ferro

  18. Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction

    Article • ACS Central Science, March 2022, American Chemical Society (ACS)

    Dr Vito Ferro

  19. Au‐NHC complexes with thiocarboxylate ligands: Synthesis, structure, stability, thiol exchange and in vitro anticancer activity

    Article • Applied Organometallic Chemistry, March 2022, Wiley

    Dr Vito Ferro

  20. Tumour cell-activated platelets modulate the immunological activity of CD4+, CD8+, and NK cells, which is efficiently antagonized by heparin

    Article • Cancer Immunology Immunotherapy, March 2022, Springer Science + Business Media

    Dr Vito Ferro

  21. Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections

    Article • Chemistry - A European Journal, January 2022, Wiley

    Dr Vito Ferro

  22. SARS-CoV-2 Triggers Complement Activation through Interactions with Heparan Sulfate

    Article • January 2022, Cold Spring Harbor Laboratory Press

    Dr Vito Ferro

  23. SARS‐CoV‐2 triggers complement activation through interactions with heparan sulfate

    Article • Clinical & Translational Immunology, January 2022, Wiley

    Dr Vito Ferro

  24. Development of Improved Synthetic Routes to Pixatimod (PG545), a Sulfated Oligosaccharide-Steroid Conjugate

    Article • Bioconjugate Chemistry, October 2021, American Chemical Society (ACS)

    Dr Vito Ferro

  25. From Cancer to COVID‐19: A Perspective on Targeting Heparan Sulfate‐Protein Interactions

    Article • The Chemical Record, June 2021, Wiley

    Dr Vito Ferro

  26. Corrigendum: Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured ex vivo

    Article • Frontiers in Cell and Developmental Biology, March 2021, Frontiers

    Dr Vito Ferro

  27. A Substituent‐Directed Strategy for the Selective Synthesis of L‐Hexoses: An Expeditious Route to L‐Idose

    Article • European Journal of Organic Chemistry, February 2021, Wiley

    Dr Vito Ferro

  28. Inhibition of Tumor–Host Cell Interactions Using Synthetic Heparin Mimetics

    Article • ACS Applied Materials & Interfaces, February 2021, American Chemical Society (ACS)

    Dr Vito Ferro

  29. Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain

    Article • Computational and Structural Biotechnology Journal, January 2021, Elsevier

    Dr Vito Ferro

  30. Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin

    Article • Thrombosis and Haemostasis, December 2020, Thieme Publishing Group

    Dr Vito Ferro

  31. GlycoTorch Vina: Docking Designed and Tested for Glycosaminoglycans

    Article • Journal of Chemical Information and Modeling, November 2020, American Chemical Society (ACS)

    Dr Vito Ferro

  32. Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured ex vivo

    Article • Frontiers in Cell and Developmental Biology, July 2020, Frontiers

    Dr Vito Ferro

  33. Sulfonated RAFT Copolymers as Heparin Mimetics: Synthesis, Reactivity Ratios, and Anticoagulant Activity

    Article • Macromolecular Bioscience, July 2020, Wiley

    Dr Vito Ferro

  34. A Fluorogenic Heparan Sulfate Disaccharide for the Measurement of Heparanase Activity

    Article • June 2020, American Chemical Society (ACS)

    Dr Vito Ferro

  35. Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 By Disrupting The Spike-ACE2 interaction

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Dr Vito Ferro

  36. Heparanase promotes Syndecan-1 expression to mediate fibrillar collagen and mammographic density in human breast tissue cultured ex vivo

    Article • June 2020, Cold Spring Harbor Laboratory Press

    Dr Vito Ferro

  37. GlycoTorch Vina: Improved Docking of Sulfated Sugars Using QM-derived Scoring Functions

    Article • May 2020, American Chemical Society (ACS)

    Dr Vito Ferro

  38. PI-88 and Related Heparan Sulfate Mimetics

    Article • January 2020, Springer Science + Business Media

    Dr Vito Ferro

  39. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment

    Article • January 2020, Elsevier

    Dr Vito Ferro

  40. Structural insights into heparanase activity using a fluorogenic heparan sulfate disaccharide

    Article • Chemical Communications, January 2020, Royal Society of Chemistry

    Dr Vito Ferro

  41. Anticoagulant Heparin Mimetics via RAFT Polymerization

    Article • Biomacromolecules, December 2019, American Chemical Society (ACS)

    Dr Vito Ferro

  42. Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions

    Article • ACS Chemical Neuroscience, July 2019, American Chemical Society (ACS)

    Dr Vito Ferro

  43. PG545 treatment reduces RRV-induced elevations of AST, ALT with secondary lymphoid organ alterations in C57BL/6 mice

    Article • PLoS ONE, June 2019, PLOS

    Dr Vito Ferro

  44. Dual targeting of dengue virus virions and NS1 protein with the heparan sulfate mimic PG545

    Article • Antiviral Research, May 2019, Elsevier

    Dr Vito Ferro

  45. In Vitro Enzymatic Digestibility of Glutaraldehyde-Crosslinked Chitosan Nanoparticles in Lysozyme Solution and Their Applicability in Pulmonary Drug Delivery

    Article • Molecules, April 2019, MDPI AG

    Dr Vito Ferro

  46. Cross-Species Analysis of Glycosaminoglycan Binding Proteins Reveals Some Animal Models Are “More Equal” than Others

    Article • Molecules, March 2019, MDPI AG

    Dr Vito Ferro

  47. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard

    Article • Molecules, November 2018, MDPI AG

    Dr Vito Ferro

  48. Applications of Ion Mobility-Mass Spectrometry in Carbohydrate Chemistry and Glycobiology

    Article • Molecules, October 2018, MDPI AG

    Dr Vito Ferro

  49. Structural and conformational studies of the heparan sulfate mimetic PI-88

    Article • Glycobiology, August 2018, Oxford University Press (OUP)

    Dr Vito Ferro, Professor Anthony Carroll

  50. Glycosylations of Simple Acceptors with 2-O -Acyl l -Idose or l -Iduronic Acid Donors Reveal Only a Minor Role for Neighbouring-Group Participation

    Article • European Journal of Organic Chemistry, May 2018, Wiley

    Dr Vito Ferro

  51. Heparin mimetics with anticoagulant activity

    Article • Medicinal Research Reviews, February 2018, Wiley

    Dr Vito Ferro

  52. Prophylactic Antiheparanase Activity by PG545 Is Antiviral In Vitro and Protects against Ross River Virus Disease in Mice

    Article • Antimicrobial Agents and Chemotherapy, February 2018, ASM Journals

    Dr Vito Ferro

  53. Synthesis and mass spectrometric analysis of disaccharides from methanolysis of heparan sulfate

    Article • Organic & Biomolecular Chemistry, January 2018, Royal Society of Chemistry

    Dr Vito Ferro

  54. New structural insights into the oligosaccharide phosphate fraction of Pichia ( Hansenula ) holstii NRRL Y2448 phosphomannan

    Article • Carbohydrate Research, June 2017, Elsevier

    Dr Vito Ferro, Professor Anthony Carroll

  55. Carbohydrate– N -heterocyclic carbene metal complexes: Synthesis, catalysis and biological studies

    Article • Coordination Chemistry Reviews, May 2017, Elsevier

    Dr Vito Ferro

  56. Glycosaminoglycans and Their Mimetics

    Article • Molecules, December 2016, MDPI AG

    Dr Vito Ferro

  57. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation

    Article • Molecular Pharmaceutics, April 2016, American Chemical Society (ACS)

    Dr Vito Ferro

  58. Recent advances in chitosan-based nanoparticulate pulmonary drug delivery

    Article • Nanoscale, January 2016, Royal Society of Chemistry

    Dr Vito Ferro

  59. Synthesis of Mannose-Cholesterol Conjugates for Targeted Liposomal Drug Delivery

    Article • ChemistrySelect, January 2016, Wiley

    Dr Vito Ferro

  60. The Tortoise and the Hare: Evolving Regulatory Landscapes for Biosimilars

    Article • Trends in Biotechnology, January 2016, Elsevier

    Dr Vito Ferro, Ross Barnard

  61. The stereoselectivities of tributyltin hydride-mediated reductions of 5-bromo-d-glucuronides tol-iduronides are dependent on the anomeric substituent: syntheses and DFT calculations

    Article • Organic & Biomolecular Chemistry, January 2016, Royal Society of Chemistry

    Dr Vito Ferro

  62. Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk

    Article • Journal of Mammary Gland Biology and Neoplasia, October 2015, Springer Science + Business Media

    Dr Vito Ferro

  63. Investigations into the decomposition of aminoacyl-substituted monosaccharide scaffolds from a drug discovery library

    Article • Organic & Biomolecular Chemistry, January 2015, Royal Society of Chemistry

    Dr Vito Ferro

  64. Synthetic Approaches to l-Iduronic Acid and l-Idose

    Article • January 2015, Elsevier

    Dr Vito Ferro

  65. Synthesis and Toxicological Evaluation of a Chitosan- l -Leucine Conjugate for Pulmonary Drug Delivery Applications

    Article • Biomacromolecules, October 2014, American Chemical Society (ACS)

    Dr Vito Ferro

  66. ChemInform Abstract: Attempted Synthesis of the Imidazylate (III) of an α-Hydroxylactone (I) Results in Unexpected Chlorination: Synthesis and X-Ray Crystal Structure of 5-Chloro-5-deoxy-1,2-O-isopropylidene-β-L-idurono-6,3-lactone (II).

    Article • ChemInform, October 2014, Wiley

    Dr Vito Ferro

  67. Attempted Synthesis of the Imidazylate of an α-Hydroxylactone Results in Unexpected Chlorination: Synthesis and X-Ray Crystal Structure of 5-Chloro-5-deoxy-1,2-O-isopropylidene-β-l-idurono-6,3-lactone

    Article • Journal of Carbohydrate Chemistry, May 2014, Taylor & Francis

    Dr Vito Ferro

  68. Low-molecular-weight heparin biosimilars: potential implications for clinical practice

    Article • Internal Medicine Journal, May 2014, Wiley

    Ross McKinnon, Dr Vito Ferro

  69. 1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase

    Article • Biochemical and Biophysical Research Communications, January 2014, Elsevier

    Dr Vito Ferro

  70. Structure and stereochemistry of an anti-inflammatory anhydrosugar from the Australian marine sponge Plakinastrella clathrata and the synthesis of two analogues

    Article • Tetrahedron, September 2013, Elsevier

    Dr Vito Ferro

  71. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses

    Article • Expert Opinion on Therapeutic Targets, June 2013, Informa Healthcare

    Dr Vito Ferro

  72. ChemInform Abstract: A Focused Sulfated Glycoconjugate Ugi Library for Probing Heparan Sulfate-Binding Angiogenic Growth Factors.

    Article • ChemInform, February 2013, Wiley

    Dr Vito Ferro

  73. MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells

    Article • Cancer Research, January 2013, American Association for Cancer Research (AACR)

    Dr Vito Ferro

  74. A focused sulfated glycoconjugate Ugi library for probing heparan sulfate-binding angiogenic growth factors

    Article • Bioorganic & Medicinal Chemistry Letters, October 2012, Elsevier

    Dr Vito Ferro

  75. Synthesis of Disaccharides Containing 6-Deoxy-a-L-talose as Potential Heparan Sulfate Mimetics

    Article • Molecules, August 2012, MDPI AG

    Dr Vito Ferro

  76. Synthesis of a Heparan Sulfate Mimetic Library Targeting FGF and VEGF via Click Chemistry on a Monosaccharide Template

    Article • ChemMedChem, May 2012, Wiley

    Dr Vito Ferro

  77. Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis

    Article • Journal of Medicinal Chemistry, April 2012, American Chemical Society (ACS)

    Dr Vito Ferro, Job Harenberg

  78. Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate

    Article • Antiviral Research, January 2012, Elsevier

    Dr Vito Ferro

  79. PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models

    Article • British Journal of Cancer, February 2011, Springer Science + Business Media

    Dr Vito Ferro

  80. Synthesis of simple heparanase substrates

    Article • Organic & Biomolecular Chemistry, January 2011, Royal Society of Chemistry

    Dr Vito Ferro

  81. Lipophile-conjugated sulfated oligosaccharides as novel microbicides against HIV-1

    Article • Antiviral Research, June 2010, Elsevier

    Dr Vito Ferro

  82. A highly lipophilic sulfated tetrasaccharide glycoside related to muparfostat (PI-88) exhibits virucidal activity against herpes simplex virus

    Article • Antiviral Research, May 2010, Elsevier

    Dr Vito Ferro

  83. Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth

    Article • Journal of Medicinal Chemistry, February 2010, American Chemical Society (ACS)

    Dr Vito Ferro, Job Harenberg

  84. Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening

    Article • Analytical Biochemistry, January 2010, Elsevier

    Dr Vito Ferro

  85. Synthesis of a heparan sulfate mimetic disaccharide with a conformationally locked residue from a common intermediate

    Article • Carbohydrate Research, November 2009, Elsevier

    Dr Vito Ferro

  86. ChemInform Abstract: An Improved Synthetic Route to the Potent Angiogenesis Inhibitor Benzyl Manα(1→3)Manα(1→3)-Manα (1→3)Manα(1→2)-Man Hexadecasulfate.

    Article • ChemInform, October 2009, Wiley

    Dr Vito Ferro

  87. The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy

    Article • Investigational New Drugs, April 2009, Springer Science + Business Media

    Dr Vito Ferro

  88. An Improved Synthetic Route to the Potent Angiogenesis Inhibitor Benzyl Manα(1→3)-Manα(1→3)-Manα(1→3)-Manα(1→2)-Man Hexadecasulfate

    Article • Australian Journal of Chemistry, January 2009, CSIRO Publishing

    Dr Vito Ferro

  89. A surface plasmon resonance-based solution affinity assay for heparan sulfate-binding proteins

    Article • Glycoconjugate Journal, November 2008, Springer Science + Business Media

    Dr Vito Ferro

  90. Synthesis and heparanase inhibitory activity of sulfated mannooligosaccharides related to the antiangiogenic agent PI-88

    Article • Bioorganic & Medicinal Chemistry, January 2008, Elsevier

    Dr Vito Ferro

  91. Design, synthesis, FGF-1 binding, and molecular modeling studies of conformationally flexible heparin mimetic disaccharides

    Article • Bioorganic & Medicinal Chemistry Letters, January 2008, Elsevier

    Dr Vito Ferro

  92. Molecular basis for resistance of herpes simplex virus type 1 mutants to the sulfated oligosaccharide inhibitor PI-88

    Article • Virology, October 2007, Elsevier

    Dr Vito Ferro

  93. Herpes Simplex Virus Type 2 Glycoprotein G Is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of Virus Attachment to Cells

    Article • Journal of Virology, September 2007, ASM Journals

    Dr Vito Ferro

  94. PI-88 and Novel Heparan Sulfate Mimetics Inhibit Angiogenesis

    Article • Seminars in Thrombosis and Hemostasis, July 2007, Thieme Publishing Group

    Dr Vito Ferro

  95. Enantiospecific synthesis of the heparanase inhibitor (+)-trachyspic acid and stereoisomers from a common precursor

    Article • Organic & Biomolecular Chemistry, January 2007, Royal Society of Chemistry

    Dr Vito Ferro

  96. Inhibition of Plasmodium falciparum Growth In Vitro and Adhesion to Chondroitin-4-Sulfate by the Heparan Sulfate Mimetic PI-88 and Other Sulfated Oligosaccharides

    Article • Antimicrobial Agents and Chemotherapy, August 2006, ASM Journals

    Dr Vito Ferro

  97. Synthesis, Biological Activity, and Preliminary Pharmacokinetic Evaluation of Analogues of a Phosphosulfomannan Angiogenesis Inhibitor (PI-88)

    Article • Journal of Medicinal Chemistry, December 2005, American Chemical Society (ACS)

    Dr Vito Ferro

  98. Towards the synthesis of aryl glucuronides as potential heparanase probes. An interesting outcome in the glycosidation of glucuronic acid with 4-hydroxycinnamic acid

    Article • Carbohydrate Research, September 2005, Elsevier

    Dr Vito Ferro

  99. The Synthesis and Biological Evaluation of Two Analogues of the C-Riboside Showdomycin.

    Article • ChemInform, July 2005, Wiley

    Dr Vito Ferro

  100. Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins

    Article • Journal of Biological Chemistry, March 2005, Elsevier

    Dr Vito Ferro

  101. The Synthesis and Biological Evaluation of Two Analogues of the C -Riboside Showdomycin

    Article • Australian Journal of Chemistry, January 2005, CSIRO Publishing

    Dr Vito Ferro

  102. The synthesis of phosphorylated disaccharide components of the extracellular phosphomannan of Pichia (Hansenula) holstii NRRL Y-2448

    Article • Bioorganic & Medicinal Chemistry, December 2004, Elsevier

    Dr Vito Ferro

  103. A Synthetic Heparanase Inhibitor Reduces Proteinuria in Passive Heymann Nephritis

    Article • Journal of the American Society of Nephrology, November 2004, Wolters Kluwer Health

    Dr Vito Ferro

  104. Application of the Four-Component Ugi Condensation for the Preparation of Sulfated Glycoconjugate Libraries.

    Article • ChemInform, September 2004, Wiley

    Dr Vito Ferro

  105. The Development of Inhibitors of Heparanase, a Key Enzyme Involved in Tumour Metastasis, Angiogenesis and Inflammation

    Article • Mini-Reviews in Medicinal Chemistry, August 2004, Bentham Science Publishers

    Dr Vito Ferro

  106. The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus

    Article • Antiviral Research, July 2004, Elsevier

    Dr Vito Ferro

  107. Application of the four-component Ugi condensation for the preparation of sulfated glycoconjugate libraries

    Article • Bioorganic & Medicinal Chemistry Letters, May 2004, Elsevier

    Dr Vito Ferro

  108. Probing the Interactions of Phosphosulfomannans with Angiogenic Growth Factors by Surface Plasmon Resonance

    Article • Journal of Medicinal Chemistry, October 2003, American Chemical Society (ACS)

    Dr Vito Ferro

  109. Preparation and anticoagulant activity of the phosphosulfomannan PI-88

    Article • European Journal of Medicinal Chemistry, October 2002, Elsevier

    Dr Vito Ferro

  110. PROBING THE INTERACTIONS OF PI-88 WITH ANGIOGENIC GROWTH FACTORS BY SURFACE PLASMON RESONANCE

    Article • April 2002, Hindawi Publishing Corporation

    Dr Vito Ferro

  111. SULFATED OLIGOSACCHARIDE-BASED INHIBITORS OF TUMOUR GROWTH AND METASTASIS

    Article • April 2002, Hindawi Publishing Corporation

    Dr Vito Ferro

  112. INHIBITION OF HERPES SIMPLEX VIRUS INFECTION BY PI-88, AN ANTAGONIST OF HEPARAN SULFATE-PROTEIN INTERACTIONS

    Article • April 2002, Hindawi Publishing Corporation

    Dr Vito Ferro

  113. HEPARAN SULFATE-MIMETICS AS INHIBITORS OF CANCER

    Article • April 2002, Hindawi Publishing Corporation

    Dr Vito Ferro

  114. Determination of the composition of the oligosaccharide phosphate fraction of Pichia (Hansenula) holstii NRRL Y-2448 phosphomannan by capillary electrophoresis and HPLC

    Article • Carbohydrate Research, February 2002, Elsevier

    Dr Vito Ferro

  115. Synthesis of [14C]- and [35S]-labelled PI-88 for pharmacokinetic and tissue distribution studies

    Article • Journal of Labelled Compounds and Radiopharmaceuticals, January 2002, Wiley

    Dr Vito Ferro

  116. Characterisation of the Anticoagulant Properties of a Range of Structurally Diverse Sulfated Oligosaccharides

    Article • Thrombosis Research, August 2001, Elsevier

    Dr Vito Ferro

  117. Large-scale preparation of the oligosaccharide phosphate fraction of Pichia holstii NRRL Y-2448 phosphomannan for use in the manufacture of PI-88

    Article • Carbohydrate Research, May 2001, Elsevier

    Dr Vito Ferro

  118. Article

    Article • Canadian Journal of Chemistry, March 1998, Canadian Science Publishing

    Dr Vito Ferro

  119. Convergent synthesis of a fluorescence-quenched glycopeptide as a potential substrate for peptide: N-glycosidases

    Article • Carbohydrate Research, January 1998, Elsevier

    Dr Vito Ferro

  120. N-Glycosyl phosphonamidates: potential transition-state analogue inhibitors of glycopeptidases

    Article • Canadian Journal of Chemistry, January 1998, Canadian Science Publishing

    Dr Vito Ferro

  121. Internally quenched fluorogenic, α-helical dimeric peptides and glycopeptides for the evaluation of the effect of glycosylation on the conformation of peptides

    Article • Journal of the Chemical Society Perkin Transactions 1, January 1997, Royal Society of Chemistry

    Dr Vito Ferro, Prof. Morten Meldal

  122. The Synthesis of Some Epoxyalkyl b-C-Glycosides as Potential Inhibitors of b-Glucan Hydrolases

    Article • Australian Journal of Chemistry, January 1997, CSIRO Publishing

    Dr Vito Ferro

  123. Analysis of the1H NMR spectra of some diethyl phosphonates

    Article • Magnetic Resonance in Chemistry, December 1994, Wiley

    Dr Vito Ferro

  124. Synthesis of 2′- and 2″-O-acylated maltotriosides as potential fluorescence-quenched substrates for α-amylase

    Article • Journal of the Chemical Society Perkin Transactions 1, January 1994, Royal Society of Chemistry

    Dr Vito Ferro, Prof. Morten Meldal

  125. Approaches to the Synthesis of Retronecine From Some Pyrrolidine Precursors

    Article • Australian Journal of Chemistry, January 1993, CSIRO Publishing

    Dr Vito Ferro

  126. The Synthesis of Some Pyrrolidines as Potential Precursors to Retronecine

    Article • Australian Journal of Chemistry, January 1993, CSIRO Publishing

    Dr Vito Ferro

  127. An Improvement in the Preparation of Some Carbohydrate Benzylidene Acetals

    Article • Australian Journal of Chemistry, January 1988, CSIRO Publishing

    Dr Vito Ferro